Health Products

Vistide

· Published by Health Canada · Official notice

Details

Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type I
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberBrand nameCompaniesDosage formDIN, NPN, DIN-HIMStrength
B1207217AA. Vistide
Recalling Firm
Gilead Sciences
333 Lakeside Drive
Foster City
94404
California
UNITED STATES
Marketing Authorization Holder
N/A
Intravenous infusionNil75 mg / mL

Introduction

Recalled Products

A. Vistide

Reason

During secondary packaging run on January 29, 2013, of another sub-lot (B120217K), vials with floating particulate matter were noted.

Depth of distribution

Shipped to 12 Canadian hospitals:
  • Alberta Children's Hospital (Calgary)
  • Children’s and Women’s HC of BC (Vancouver)
  • Canadian Forces Medical Center (Petawawa ON)
  • Winnipeg HC Center
  • Hull Hospital (Gatineau)
  • Chaleur Regional Hospital (Bathurst NB)
  • Hotel Dieu of Quebec City
  • Peter Lougheed Center (Calgary)
  • Princess Margaret Hospital (Toronto)
  • Royal Alexandra Hospital (Edmonton)
  • Royal University Hospital (Saskatoon)
  • Vancouver General Hospital
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime